Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

U.Va. researchers uncover role of platelets in hardening of the arteries

16.12.2002


Scientists at the University of Virginia School of Medicine have discovered a new contributor to atherosclerosis, the most common form of hardening of the arteries. Marked by cholesterol-calcium-lipid deposits, atherosclerosis is the main cause of heart attacks, the number one killer in the U.S. Doctors at U.Va. say research on mice has determined for the first time that activated platelets circulating in the blood, long understood as markers for atherosclerosis, really serve as participants in the process that eventually leads to atherosclerosis. The findings of the two-year study are published in the Dec. 16 online issue of the journal Nature Medicine, found at www.nature.com/naturemedicine.



"These platelets are time bombs in the blood," said Dr. Klaus Ley, director of the Cardiovascular Research Center and professor of biomedical engineering, molecular physiology and biological physics at U.Va. "The hope now is that we can develop anti-platelet drugs to limit activation, which would be a beneficial, effective preventive measure against heart attack. These important observations could translate into improved therapies for limiting this extremely prevalent disease."

There is a commonly used test for activated platelets, called flow cytometry. Ley believes some patients may want to be tested for the presence of such platelets, in addition to being tested for a compound called C-reactive protein (CRP), which increases when inflammation is present. The American Heart Association is studying whether a CRP test should be part of a routine check-up. "What was surprising is how long these activated platelets stay in the blood," Ley said.


Platelets, round or oval disks, are routinely found in blood and play an important role in clotting. Platelets are activated as part of the blood clotting response to injury or as part of the inflammatory response. They become sticky and are prone to bind with monocytes, a type of white blood cell. It’s believed aspirin plays a role in preventing heart attacks by acting on platelets.

In the study, U.Va. researchers injected activated platelets into mice engineered to have high cholesterol levels (1000 vs. 200 for humans) and studied the interaction with human aortic endothelial cells. They found that activated platelets were able to deposit pro-inflammatory factors, or chemokines, on monocytes and vessel walls, a key element in the formation of atherosclerotic lesions, or altered tissue. The researchers also found that a protein called platelet P-selectin is indispensable for the interaction of the platelets in the formation of atherosclerotic lesions. Researchers at University Hospital in Aachen, Germany and at the Howard Hughes Medical Institute in New York contributed to the study.



*Note: Dr. Ley can be reached for comment at: 434-243-9966 (office) or 434-974-9265 (home) or by email: klausley@virginia.edu.


Bob Beard | EurekAlert!
Further information:
http://www.nature.com/naturemedicine
http://hsc.virginia.edu/news

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>